MedTrace Logo

Antibiotic Prophylaxis in Gynecologic Laparoscopy

NCT01991834 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 114

Last updated 2015-04-27

No results posted yet for this study

Summary

Laparoscopy is a surgical procedure indicated for most gynecological pathologies and presents numerous advantages over laparotomy, among them lower rates of surgical site infection and less comorbidity feverish. Despite this, the use of antibiotic prophylaxis is widely accepted and performed by most gynecologists. However, there isn't literature evidence to support the routine use of antibiotics in the prophylaxis of wound infection on laparoscopic pelvic surgery .Therefore, this study will evaluate the need for the use of antibiotic prophylaxis in gynecological laparoscopies not including opening hollow viscera.

Conditions

  • Infection Secondary to Surgical Procedure

Interventions

PROCEDURE

gynecologic laparoscopy

Gynecological laparoscopy without opening hollow viscera.

DRUG

Cefazolin

Intravenous administration of 1 g of cefazolin

DRUG

Placebo

Intravenous administration of saline sterile solution

Sponsors & Collaborators

  • Universidade do Vale do Sapucai

    lead OTHER

Principal Investigators

  • Fabiola SM Campos, MD · Universidade do Vale do Sapucai

  • Daniela F Veiga, MD, PhD · Universidade do Vale do Sapucai

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2015-03-31
Completion
2015-04-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01991834 on ClinicalTrials.gov